2.66 MEUR
111.24 M
About WPD PHARMACEUTICALS INC.
Sector
Industry
CEO
Mariusz Olejniczak
Website
Headquarters
Vancouver
Founded
2006
FIGI
BBG00RJVXF47
WPD Pharmaceuticals, Inc. is a biotechnology research and development company, which engages in the research and development of medicinal products involving biological compounds and small molecules. Its products include WPD101, Berubicin, WP1066, WP1732, WPD102, WPD103, WP1220, and Annamycin. The company was founded on July 4, 2006 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WPD PHARMACEUTICALS stocks are traded under the ticker 8SV1.
Yes, you can track WPD PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
8SV1 net income for the last quarter is −59.78 K EUR, while the quarter before that showed −54.40 K EUR of net income which accounts for −9.90% change. Track more WPD PHARMACEUTICALS financial stats to get the full picture.
No, 8SV1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8SV1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WPD PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.